Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season

被引:111
|
作者
Belongia, Edward A. [1 ]
Sundaram, Maria E. [1 ]
McClure, David L. [1 ]
Meece, Jennifer K. [1 ]
Ferdinands, Jill [2 ,3 ]
VanWormer, Jeffrey J. [1 ]
机构
[1] Marshfield Clin Res Fdn, Marshfield, WI 54449 USA
[2] US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA
[3] Battelle Mem Inst, Atlanta, GA USA
关键词
Influenza; Influenza vaccine; Immunity; Vaccine effectiveness; EFFICACY; ANTIBODY;
D O I
10.1016/j.vaccine.2014.06.052
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Recent studies have suggested that vaccine-induced protection against influenza may decline within one season. We reanalyzed data from a study of influenza vaccine effectiveness to determine if time since vaccination was an independent predictor of influenza A (H3N2). Methods: Patients with acute respiratory illness were actively recruited during the 2007-2008 season. Respiratory swabs were tested for influenza, and vaccination dates were determined by a validated immunization registry. The association between influenza RT-PCR result and vaccination interval (days) was examined using multivariable logistic regression, adjusting for calendar time, age and other confounders. Results: There were 629 vaccinated participants, including 177 influenza A (H3N2) cases and 452 test negative controls. The mean (SD) interval from vaccination to illness onset was 101.7 (25.9) days for influenza cases and 93.0 (29.9) days for controls. There was a significant association between vaccination interval and influenza result in the main effects model. The adjusted odds ratio (a0R) for influenza was 1.12 (CI 1.01, 1.26) for every 14 day increase in the vaccination interval. Age modified the association between vaccination interval and influenza (p = 0.005 for interaction). Influenza was associated with increasing vaccination interval in young children and older adults, but not in adolescents or non-elderly adults. Similar results were found when calendar week of vaccine receipt was assessed as the primary exposure variable. Conclusions: Identification of influenza A (H3N2) was associated with increasing time since vaccination among young children and older adults during a single influenza season. (C) 2014 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:246 / 251
页数:6
相关论文
共 50 条
  • [21] Neurologic Manifestations of Influenza A(H3N2) Infection in Children During the 2016-2017 Season
    Rao, Suchitra
    Martin, Jan
    Ahearn, M. Alex
    Osborne, Christina
    Moss, Angela
    Dempsey, Amanda
    Dominguez, Samuel R.
    Weinberg, Adriana
    Messacar, Kevin B.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2020, 9 (01) : 71 - 74
  • [22] Single radial haemolysis compared to haemagglutinin inhibition and microneutralization as a correlate of protection against influenza A H3N2 in children and adolescents
    Wang, Biao
    Russell, Margaret L.
    Brewer, Angela
    Newton, Jennifer
    Singh, Pardeep
    Ward, Brian J.
    Loeb, Mark
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2017, 11 (03) : 283 - 288
  • [23] Humoral Correlates of Protection Against Influenza A/H3N2 Virus Infection
    Hoy, Gregory
    Stadlbauer, Daniel
    Balmaseda, Angel
    Kuan, Guillermina
    Lopez, Roger
    Quiroz, Juan Manuel Carreno
    Ojeda, Sergio
    Sanchez, Nery
    Yellin, Temima
    Plazaola, Miguel
    Frutos, Aaron
    Krammer, Florian
    Gordon, Aubree
    JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (06) : 1319 - 1328
  • [24] Influenza vaccine effectiveness estimates against influenza A(H3N2) and A(H1N1) pdm09 among children during school-based outbreaks in the 2016-2017 season in Beijing, China
    Zhang, Li
    van der Hoek, Wim
    Krafft, Thomas
    Pilot, Eva
    van Astenc, Liselotte
    Lin, Ge
    Wu, Shuangsheng
    Duan, Wei
    Yang, Peng
    Wang, Quanyi
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (04) : 816 - 822
  • [25] Ineffectiveness of the 2014-2015 H3N2 influenza vaccine
    Mandelboim, Michal
    Glatman-Freedman, Aharona
    Drori, Yaron
    Sherbany, Hilda
    Pando, Rakefet
    Sefty, Hanna
    Zadka, Hila
    Shohat, Tamar
    Keller, Nathan
    Mendelson, Ella
    ONCOTARGET, 2016, 7 (02) : 1185 - 1192
  • [26] Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network
    Rose, Angela M. C.
    Pozo, Francisco
    Martinez-Baz, Ivan
    Mazagatos, Clara
    Bossuyt, Nathalie
    Cauchi, John Paul
    Petrovic, Goranka
    Loghin, Isabela I.
    Vaikutyte, Roberta
    Buda, Silke
    Machado, Ausenda
    Duffy, Roisin
    Oroszi, Beatrix
    Howard, Jennifer
    Echeverria, Aitziber
    Andreu, Cristina
    Barbezange, Cyril
    Dziugyte, Ausra
    Nonkovic, Diana
    Popescu, Corneliu-Petru
    Majauskaite, Fausta
    Tolksdorf, Kristin
    Gomez, Veronica
    Domegan, Lisa
    Horvath, Judit Krisztina
    Castilla, Jesus
    Garcia, Miriam
    Demuyser, Thomas
    Borg, Maria-Louise
    Tabain, Irena
    Lazar, Mihaela
    Kubiliute, Ieva
    Duerrwald, Ralf
    Guiomar, Raquel
    O'Donnell, Joan
    Kristof, Katalin
    Nicolay, Nathalie
    Bacci, Sabrina
    Kissling, Esther
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (02)
  • [27] Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016-17 and 2017-18)
    Kissling, Esther
    Pozo, Francisco
    Buda, Silke
    Vilcu, Ana-Maria
    Rizzo, Caterina
    Gherasim, Alin
    Horvath, Judit Krisztina
    Brytting, Mia
    Domegan, Lisa
    Meijer, Adam
    Paradowska-Stankiewicz, Iwona
    Machado, Ausenda
    Vucina, Vesna Visekruna
    Lazar, Mihaela
    Johansen, Kari
    Durrwald, Ralf
    van der Werf, Sylvie
    Bella, Antonino
    Larrauri, Amparo
    Ferenczi, Annamaria
    Zakikhany, Katherina
    O'Donnell, Joan
    Dijkstra, Frederika
    Bogusz, Joanna
    Guiomar, Raquel
    Filipovic, Sanja Kurecic
    Pitigoi, Daniela
    Penttinen, Pasi
    Valenciano, Marta
    VACCINE: X, 2019, 3
  • [28] Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses
    Allen, James D.
    Jang, Hyesun
    DiNapoli, Joshua
    Kleanthous, Harold
    Ross, Ted M.
    JOURNAL OF VIROLOGY, 2019, 93 (03)
  • [29] Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015
    Gilca, Rodica
    Skowronski, Danuta M.
    Douville-Fradet, Monique
    Amini, Rachid
    Boulianne, Nicole
    Rouleau, Isabelle
    Martineau, Christine
    Charest, Hugues
    De Serres, Gaston
    PLOS ONE, 2015, 10 (07):
  • [30] Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network
    Rondy, M.
    Castilla, J.
    Launay, O.
    Costanzo, S.
    Ezpeleta, C.
    Galtier, F.
    Donati, K. de Gaetano
    Moren, A.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (05) : 1217 - 1224